Navigation Links
Advancements in Endocrine Testing, New Life Science Webinar Hosted by Xtalks
Date:7/25/2013

Toronto, Canada (PRWEB) July 25, 2013

Diabetes is the seventh leading cause of death in the U.S. and affects over 350 million people worldwide, according to the World Health Organization. It is estimated that one in six men will be diagnosed with prostate cancer in their lifetime — the second most common cancer in the world.

Not surprisingly, drug developers are currently working on over 500 clinical trials for hormone or steroid-driven diseases, such as prostate cancer, diabetes and other metabolic diseases.

Detection of very low levels of hormones and related molecules are an important facet of monitoring investigational agents that target these diseases and allows for a more informed understanding of drug response and optimization of dose, regimen and treatment during clinical development.

In this webinar, an overview of clinically relevant assays for ultrasensitive endocrine clinical trial testing services will be discussed by LabCorp scientists, Dr. Walt Chandler, Head of R&D for Endocrine Sciences, and Dr. Patrice Hugo, Senior Director of Global Scientific Affairs.

Ongoing and future LabCorp projects, such as proprietary assays for diabetes, bone metabolism, thyroid and adrenal function, development and reproduction using age-related reference ranges will also be highlighted in this presentation.

To learn more about the event, visit http://www.xtalks.com/advancements-in-endocrine-testing.ashx.

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks, visit http://xtalks.com/ContactUs.ashx.

Contact:
Karen Lim (416) 977-6555 ext 227
clientservices(at)xtalks(dot)com

Read the full story at http://www.prweb.com/releases/2013/7/prweb10961818.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Bend Research Presents Drug Delivery Advancements at Controlled Release Society Annual Meeting
2. Further Advancements Made in the Development of an Improved Method For Rape Kit Testing Using Pressure BioSciences Patented Pressure Cycling Technology (PCT)
3. P&G Beauty & Grooming to present advancements in skin aging & stress sweat at AAD Meeting
4. Empire Genomics Licenses Novel DNA Biomarker for Use in Diagnosing and Creating a Companion Diagnostic Test for Neuroendocrine Prostate Cancer
5. Biscayne Pharmaceuticals Closes $1.5 Million Financing To Advance Recent Discoveries Of Pioneering Endocrine Drug Researcher
6. PROLOR Biotech To Present Data On Its Long-Acting Human Growth Hormone At International NeuroEndocrine Meeting
7. Global Neuroendocrine Carcinoma Therapeutics Market To Reach $475m By 2019 - Report
8. Neuroendocrine Carcinoma Therapeutics - Pipeline Assessment and Market Forecast to 2019
9. Isothermal Nucleic Acid Amplification Technologies Market 2012-2017: Molecular Diagnostics, Infectious Disease Testing, Blood Screening, Cancer Research, Rapid Testing
10. Effective Strategies for Managing Comparator Product Testing, New Webinar Hosted by Xtalks
11. Infectious Disease Prevalence and New Strains Appearing Each Year Makes a Watertight Case for Clinical Laboratory Testing, Finds Frost & Sullivan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2017)... ... ... The AMA is happy to announce that $48,000 in scholarships will be ... are created through funds donated by model aviation organizations and individuals, AMA members, and ... Scholarship Committee, which is made up of model aviation pilots and enthusiasts. The committee ...
(Date:4/20/2017)... April 20, 2017  Eli Lilly and Company (NYSE: ... evaluating galcanezumab for the prevention of migraine at the ... take place April 22-28, 2017, in Boston ... abstracts at AAN, including safety and patient outcomes data ... with a reduction in monthly migraine headache days among ...
(Date:4/20/2017)... ... 20, 2017 , ... Energetiq Technology , a world ... Chief Executive Officer (CEO) Debbie Gustafson has been appointed to the SEMI North ... connecting the electronics manufacturing supply chain. The mission of the SEMI NAAB is ...
(Date:4/20/2017)... April 20, 2017 For today, Stock-Callers.com ... novel drug development and clinical research aimed at treating diseases ... (NASDAQ: BSTG), Keryx Biopharmaceuticals Inc. (NASDAQ: KERX), Kite Pharma Inc. ... ). You can access our complimentary research reports on these ... ...
Breaking Biology Technology:
(Date:4/11/2017)... , Apr. 11, 2017 Research and Markets ... 2017-2021" report to their offering. ... The global eye tracking market to grow at a CAGR ... Global Eye Tracking Market 2017-2021, has been prepared based on an ... the market landscape and its growth prospects over the coming years. ...
(Date:4/11/2017)... -- NXT-ID, Inc. (NASDAQ:   NXTD ) ("NXT-ID" ... of independent Directors Mr. Robin D. Richards and ... furthering the company,s corporate governance and expertise. ... Gino Pereira , Chief Executive Officer ... guidance and benefiting from their considerable expertise as we move ...
(Date:4/5/2017)... -- The Allen Institute for Cell Science today announces the ... and dynamic digital window into the human cell. The ... of deep learning to create predictive models of cell ... growing suite of powerful tools. The Allen Cell Explorer ... available resources created and shared by the Allen Institute ...
Breaking Biology News(10 mins):